Standardization of CD3+ T Cell Dose for Patients Receiving Allogeneic Peripheral Blood Stem Cell Transplantation From Matched Related Donors
This study is currently recruiting participants.
Verified November 2017 by Ayman Saad, University of Alabama at Birmingham
First Posted: August 14, 2009
Last Update Posted: November 6, 2017
Miltenyi Biotec, Inc.
Information provided by (Responsible Party):
Ayman Saad, University of Alabama at Birmingham
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||October 2021|
|Estimated Primary Completion Date:||October 2019 (Final data collection date for primary outcome measure)|